Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PHC HoldingsTSE:6523 +3.77%53 EV-to-EBITDA is 7.80 as of Aug. 31, 2026, which is 2% below its 10-year median of 7.94. GuruFocus rates TSE:6523 with a GF Score™ of 53/100 and a GF Value™ of 円1,102.52 (Significantly Overvalued). The stock has 12 warning signs investors should review. Among 520 Medical Devices & Instruments companies, PHC Holdings ranks better than 75.96% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PHC Holdings's enterprise value is 円391,196 Mil.
PHC Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円50,149 Mil. Therefore, PHC Holdings's EV-to-EBITDA for today is 7.80.
The historical rank and industry rank for PHC Holdings's EV-to-EBITDA or its related term are showing as below:
TSE:6523'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.12 Med: 7.94 Max: 20.09
Current: 7.8
During the past 8 years, the highest EV-to-EBITDA of PHC Holdings was 20.09. The lowest was 5.12. And the median was 7.94.
TSE:6523's EV-to-EBITDA is ranked better than 75.96% of 520
companies
in the Medical Devices & Instruments industry
Industry Median: 14.68
vs TSE:6523: 7.80
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PHC Holdings's PE Ratio (TTM) for today is calculated as:
PHC Holdings's share price for today is 円1598.00.
PHC Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3.870.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for PHC Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6523 vs ABT, SYK, MDT: EV-to-EBITDA Comparison
For the Medical Devices subindustry, PHC Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PHC Holdings EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PHC Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PHC Holdings's EV-to-EBITDA falls into.
PHC Holdings's current Enterprise Value is 円391,196 Mil.
PHC Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円50,149 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHC Holdings (TSE:6523) has a EV-to-EBITDA of 7.80 as of Aug. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PHC Holdings. This is near median its historical median of 7.94. Over the past decade, PHC Holdings' EV-to-EBITDA has ranged from 5.12 to 20.09. According to the industry distribution chart, PHC Holdings ranks #125 out of 520 companies in the Medical Devices & Instruments industry, placing it in the top 24%.
Is PHC Holdings' EV-to-EBITDA too high?
PHC Holdings' current EV-to-EBITDA of 7.80 is near median its 10-year median of 7.94. Over the past 10 years, this metric has ranged from a low of 5.12 to a high of 20.09. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.68. PHC Holdings' value of 7.80 is 46.9% below this industry median. Based on the distribution chart, PHC Holdings ranks #125 out of 520 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PHC Holdings has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PHC Holdings' EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PHC Holdings ranks #125 out of 520 companies for EV-to-EBITDA. This places PHC Holdings in the top 24% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 14.68. PHC Holdings' value of 7.80 is 46.9% below this benchmark. Historically, PHC Holdings' own EV-to-EBITDA has ranged from 5.12 to 20.09 over the past decade. While the company's 10-year median is 7.94 vs. the industry median of 14.68, PHC Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.68, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PHC Holdings's current EV-to-EBITDA of 7.80 is 46.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PHC Holdings. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PHC Holdings's current EV-to-EBITDA is 7.80, which is near median its own 10-year median of 7.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PHC Holdings stock overvalued right now?
Based on GuruFocus' analysis, PHC Holdings (TSE:6523) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,102.52, compared to a current price of 円1,598.00 — trading 44.9% above its estimated fair value. The current EV-to-EBITDA is 7.80, which is near median its 10-year median of 7.94 and 46.9% below the Medical Devices & Instruments industry median of 14.68. PHC Holdings' overall GF Score™ is 53/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For PHC Holdings (TSE:6523), the current EV-to-EBITDA is 7.80 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PHC Holdings (TSE:6523) Overvalued in 2026?
Based on GuruFocus' analysis, PHC Holdings stock appears to be overvalued.
The current stock price of 円1,598.00 is trading 44.9% above its estimated GF Value™ of 円1,102.52.
GuruFocus considers PHC Holdings to be Significantly Overvalued.
Key valuation signals for TSE:6523:
EV-to-EBITDA: 7.80 (near median its 10-year median of 7.94)
GF Value™: 円1,102.52 vs. price of 円1,598.00 (44.9% above fair value)
Industry Position: 46.9% below the Medical Devices & Instruments median (#125 of 520)
No single metric tells the full story. See the TSE:6523 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6523 has been successfully added to your 
